SOX9 and neoplasm: Overall, our findings from in-depth analysis of the TCGA data bolster the view that SOX9 functions as a tumor suppressor in a notable subset of human CRCs, with loss of SOX9 expression and function promoting tumor progression and invasion and poorer patient outcomes.